Dr. Darren Kocs, MD
What this data tells you about Dr. Kocs
Dr. Darren Kocs is a medical oncology in Round Rock, TX, with 19 years in practice. Based on federal Medicare data, Dr. Kocs performed 366,526 Medicare services across 6,847 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kocs received a total of $267 from 8 pharmaceutical and/or device companies across 18 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kocs is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) | 104,000 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 66,875 | $2 | $20 |
| Azacitidine chemotherapy injection | 44,400 | $0 | $13 |
| Pembrolizumab injection (Keytruda) | 33,200 | $43 | $137 |
| Testosterone injection | 16,600 | $0 | $1 |
| Anti-nausea injection (aprepitant) | 15,730 | $1 | $8 |
| Anti-nausea injection (fosaprepitant) | 14,250 | $0 | $5 |
| Contrast dye for imaging (iodine-based) | 14,200 | $0 | $3 |
| Paclitaxel chemotherapy injection | 9,534 | $0 | $8 |
| Dexamethasone injection (steroid) | 8,022 | $0 | $1 |
| Injection, granisetron hydrochloride, 100 mcg | 5,103 | $0 | $24 |
| Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 3,790 | $22 | $181 |
| Complete blood count (CBC) with differential | 2,464 | $8 | $36 |
| Anti-nausea injection (Aloxi/palonosetron) | 2,370 | $1 | $114 |
| Injection of additional new drug or substance into vein | 2,168 | $11 | $108 |
| Comprehensive metabolic blood panel | 2,127 | $10 | $64 |
| Blood draw (venipuncture) | 2,100 | $8 | $20 |
| Injection, magnesium sulfate, per 500 mg | 1,884 | $1 | $6 |
| Administration of chemotherapy into vein, 1 hour or less | 1,187 | $96 | $707 |
| Magnesium level test | 1,019 | $7 | $29 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,005 | $22 | $157 |
| Injection, leucovorin calcium, per 50 mg | 1,001 | $3 | $25 |
| Injection, fluorouracil, 500 mg | 917 | $2 | $13 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 866 | $47 | $313 |
| Immunoglobulin level test | 651 | $9 | $56 |
| Injection, potassium chloride, per 2 meq | 570 | $0 | $1 |
| Ferritin level test (iron stores) | 471 | $13 | $60 |
| Iron level test | 471 | $6 | $27 |
| Iron binding capacity test | 471 | $9 | $35 |
| Office visit, established patient, complex (40-54 min) | 440 | $131 | $496 |
| Flow cytometry, additional marker | 434 | $20 | $180 |
| Drug injection, under skin or into muscle | 432 | $10 | $96 |
| Lactate dehydrogenase (enzyme) level | 421 | $6 | $31 |
| Office visit, established patient (30-39 min) | 410 | $87 | $368 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 403 | $15 | $100 |
| Injection, zoledronic acid, 1 mg | 384 | $7 | $431 |
| Measurement of immunoglobulin light chains | 350 | $17 | $60 |
| Infusion, normal saline solution , 1000 cc | 349 | $2 | $19 |
| Administration of chemotherapy into vein, each additional hour | 345 | $21 | $161 |
| Injection, diphenhydramine hcl, up to 50 mg | 344 | $1 | $7 |
| Reticulated (young) platelet measurement | 330 | $35 | $143 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 306 | $3 | $14 |
| Microscopic examination for white blood cells with manual cell count | 219 | $4 | $22 |
| Complete blood count (CBC), automated | 219 | $6 | $34 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 216 | $132 | $3,675 |
| Administration of additional new drug or substance into vein, 1 hour or less | 198 | $47 | $344 |
| Unclassified drugs | 190 | $1 | $8 |
| Uric acid level test | 187 | $4 | $25 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 187 | $1 | $19 |
| Infusion into a vein for hydration, 31-60 minutes | 177 | $24 | $256 |
| Infusion into a vein for hydration, each additional hour | 165 | $9 | $75 |
| Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | 157 | $71 | $70 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 155 | $90 | $657 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 129 | $1,130 | $4,802 |
| Immunologic analysis technique on serum | 123 | $29 | $108 |
| Protein measurement, serum | 122 | $11 | $99 |
| Immunologic analysis technique on serum (immunofixation) | 120 | $22 | $160 |
| Administration of additional new drug or substance into vein using push technique | 113 | $40 | $289 |
| Ct scan of chest with contrast | 109 | $45 | $821 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 105 | $124 | $500 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 105 | $1 | $17 |
| Phosphate level test | 100 | $5 | $24 |
| Drawing of blood for a medical problem | 97 | $65 | $264 |
| CT scan of abdomen and pelvis with contrast | 86 | $156 | $1,067 |
| Irrigation of implanted venous access drug delivery device | 86 | $18 | $114 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 72 | $23 | $145 |
| New patient office visit (45-59 min) | 68 | $111 | $565 |
| Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | 67 | $271 | $2,762 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 64 | $14 | $94 |
| New patient office visit, complex (60-74 min) | 62 | $154 | $709 |
| Red blood count automated, with additional calculations | 55 | $5 | $26 |
| Hospital follow-up visit, high complexity | 48 | $88 | $357 |
| Automated urinalysis | 45 | $2 | $16 |
| Nuclear medicine study whole body with ct scan | 33 | $1,097 | $4,929 |
| Beta-2 microglobulin (protein) level | 30 | $15 | $96 |
| Initial hospital admission, high complexity | 28 | $128 | $694 |
| Hospital follow-up visit, moderate complexity | 28 | $57 | $247 |
| Urinalysis with microscopic exam | 27 | $3 | $28 |
| Office visit, established patient (20-29 min) | 26 | $66 | $250 |
| Ct scan of soft tissue of neck with contrast | 22 | $61 | $658 |
| Flow cytometry technique for dna or cell analysis, first marker | 18 | $59 | $298 |
| Flu vaccine, quadrivalent | 16 | $76 | $171 |
| Flu vaccine administration | 16 | $30 | $58 |
| CT scan of chest, without contrast | 15 | $48 | $686 |
| Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev | 14 | $178 | $700 |
| Basic metabolic blood panel | 13 | $8 | $49 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (74%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kocs is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and speaking/promotional industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kocs experienced with iron sucrose injection (venofer)?
Does Dr. Kocs receive payments from pharmaceutical companies?
How do Dr. Kocs's costs compare to other medical oncologys in Round Rock?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology